More Drugs Show Promise in Fighting Hepatitis C - HealthDay Article
More Drugs Show Promise in Fighting Hepatitis CFaldaprevir and deleobuvir are part of effort to develop treatments that avoid harsh side effects
An experimental drug duo may cure some cases of the liver disease hepatitis C, without the severe side effects of standard therapy, a new clinical trial suggests.The study, of 362 people with chronic hepatitis C, found that the new drugs -- combined with one older drug -- cleared the virus from up to 69 percent of patients. And that was without having to use interferon, a difficult-to-take injection drug that is part of the current therapy.Experts said the findings, published in the Aug. 15 issue of the New England Journal of Medicine, are another step forward in vastly improving hepatitis C treatment.Dozens of drugs are in development, and some are currently being considered for approval by the U.S. Food and Drug Administration (FDA)."These are very exciting times in hepatitis C treatment," said Dr. Michael Saag, an infectious disease specialist at the University of Alabama at Birmingham who was not involved in the new study.
To read the full article, please visit: http://consumer.healthday.com/cancer-information-5/mis-cancer-news-102/experimental-drugs-may-cure-some-hepatitis-c-cases-679239.html
1300 Wilson Boulevard | Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200 | Fax: (703) 299-0204
| HIVMA | Contact Us
© Copyright IDSA 2013 Infectious Diseases Society of America